Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14279/30113
DC FieldValueLanguage
dc.contributor.authorKhatib, Rani-
dc.contributor.authorAngus, Neil J.-
dc.contributor.authorHansen, Tina B-
dc.contributor.authorLambrinou, Ekaterini-
dc.contributor.authorVellone, Ercole-
dc.contributor.authorKhan, Mutiba-
dc.contributor.authorLee, Geraldine A.-
dc.date.accessioned2023-09-07T07:16:15Z-
dc.date.available2023-09-07T07:16:15Z-
dc.date.issued2022-07-01-
dc.identifier.citationEuropean Journal of Cardiovascular Nursing, 2022, vol. 21, iss. 5, pp. 430 - 437en_US
dc.identifier.issn14745151-
dc.identifier.urihttps://hdl.handle.net/20.500.14279/30113-
dc.description.abstractInjectable medicines are increasingly used to manage risk factors for cardiovascular (CV) events, such as dyslipidaemia and diabetes. These include proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists. Little is known about perceptions of injectable therapies among CV healthcare professionals (HCPs). This study explores their views to identify relevant facilitators and barriers to the use of injectables with CV benefit.en_US
dc.formatpdfen_US
dc.language.isoenen_US
dc.relation.ispartofEuropean Journal of Cardiovascular Nursingen_US
dc.rights© The Author(s)en_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAdherenceen_US
dc.subjectGLP-1 receptor agonisten_US
dc.subjectHealthcare professionalsen_US
dc.subjectInjectableen_US
dc.subjectPCSK9 inhibitoren_US
dc.subjectSurveyen_US
dc.titlePerceptions of injectable therapies with cardiovascular benefit: an ACNAP survey of healthcare professionals to explore facilitators and barriersen_US
dc.typeArticleen_US
dc.collaborationLeeds Teaching Hospitals NHS Trusten_US
dc.collaborationUniversity of Leedsen_US
dc.collaborationUniversity of the Highlands and Islandsen_US
dc.collaborationZealand University Hospitalen_US
dc.collaborationUniversity of Southern Denmarken_US
dc.collaborationCyprus University of Technologyen_US
dc.collaborationUniversity of Rome Tor Vergataen_US
dc.collaborationMidwifery and Palliative Careen_US
dc.subject.categoryHealth Sciencesen_US
dc.journalsOpen Accessen_US
dc.countryUnited Kingdomen_US
dc.countryDenmarken_US
dc.countryCyprusen_US
dc.countryItalyen_US
dc.subject.fieldMedical and Health Sciencesen_US
dc.publicationPeer Revieweden_US
dc.identifier.doi10.1093/eurjcn/zvab106en_US
dc.identifier.pmid34849708-
dc.identifier.scopus2-s2.0-85130613126-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/85130613126-
dc.relation.issue5en_US
dc.relation.volume21en_US
cut.common.academicyear2021-2022en_US
dc.identifier.spage430en_US
dc.identifier.epage437en_US
item.fulltextWith Fulltext-
item.cerifentitytypePublications-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_6501-
item.openairetypearticle-
item.languageiso639-1en-
crisitem.journal.journalissn1873-1953-
crisitem.journal.publisherSage-
crisitem.author.deptDepartment of Nursing-
crisitem.author.facultyFaculty of Health Sciences-
crisitem.author.orcid0000-0002-2601-8861-
crisitem.author.parentorgFaculty of Health Sciences-
Appears in Collections:Άρθρα/Articles
Files in This Item:
File Description SizeFormat
lambrinou 3.pdfFull text639.18 kBAdobe PDFView/Open
CORE Recommender
Show simple item record

SCOPUSTM   
Citations 20

2
checked on May 2, 2024

WEB OF SCIENCETM
Citations

2
Last Week
0
Last month
0
checked on Nov 1, 2023

Page view(s)

106
Last Week
1
Last month
11
checked on May 9, 2024

Download(s) 20

30
checked on May 9, 2024

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons